Phase 1 Actinic Keratosis (AK) Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Evaluate RLS-1496 Topical Cream for Actinic Keratosis

Actinic Keratosis (AK)

Rubedo Life Sciences, Inc.24 enrolled4 locationsNCT07340697

Recruiting

Phase 1

A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis.

Actinic Keratosis (AK)

Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.40 enrolled1 locationNCT07318675